GO:1903464 negative regulation of mitotic cell cycle DNA replication: Cell Cycle Checkpoint Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903464 describes any process that stops, prevents, or reduces the frequency, rate, or extent of DNA replication during the mitotic cell cycle.
• This negative regulation is essential for genome stability, preventing re-replication and ensuring that DNA is duplicated exactly once per cell cycle.
• Key negative regulators include WEE1 kinase, which phosphorylates CDK1 to delay mitotic entry when replication is incomplete, and the Rb1 tumor suppressor, which restricts S-phase entry.
• Dysregulation of this process is linked to cancer, as loss of negative control leads to unscheduled DNA replication and genomic instability.
• WEE1 inhibitors are being explored as anticancer agents, but they can trigger the integrated stress response, revealing complex cross-talk with cell cycle checkpoints.
• Studying GO:1903464 requires methods such as CRISPR knockout, phospho-proteomics, and live-cell imaging to dissect the molecular brakes on DNA replication [1,5].
Description
The mitotic cell cycle is a tightly regulated sequence of events that ensures the accurate duplication and segregation of the genome. DNA replication during S phase must occur once and only once per cycle to maintain genomic integrity. The Gene Ontology term GO:1903464, negative regulation of mitotic cell cycle DNA replication, encompasses all processes that stop, prevent, or reduce the frequency, rate, or extent of DNA replication during the mitotic cell cycle. This regulation is critical for preventing re-replication and for coordinating replication with other cell cycle events such as mitosis. Researchers study this term to understand how cells safeguard their genomes and how failures in these safeguards contribute to diseases like cancer. Key negative regulators include the WEE1 kinase, which inhibits CDK1 to delay mitotic entry when replication is incomplete, and the retinoblastoma protein Rb1, which restricts S-phase entry. Understanding these mechanisms is vital for developing targeted therapies, as evidenced by ongoing clinical trials of WEE1 inhibitors. This article provides a comprehensive overview of GO:1903464, covering its definition, biological significance, key genes, regulatory mechanisms, disease associations, and experimental approaches for investigation.
negative regulation of mitotic cell cycle DNA replication At A Glance
| GO ID | GO:1903464 |
|---|---|
| GO term | negative regulation of mitotic cell cycle DNA replication |
| Ontology | biological_process |
| Synonym | inhibition of DNA replication during S phase involved in mitotic cell cycle |
| Major function | Prevents re-replication and coordinates DNA synthesis with mitosis to maintain genome stability |
| Related processes | Cell cycle checkpoint control, DNA damage response, S phase regulation [1,3] |
| Key regulators | WEE1, CDK1, Rb1, ATR, PKMYT1 [2,3,4] |
| Disease relevance | Cancer, genomic instability, chemoresistance [2,4] |
What Is GO:1903464?
GO:1903464, negative regulation of mitotic cell cycle DNA replication, is defined by the Gene Ontology as any process that stops, prevents, or reduces the frequency, rate, or extent of mitotic cell cycle DNA replication. In simpler terms, it refers to the cellular brakes that ensure DNA is copied only once per cell division cycle. This regulation is crucial for maintaining genomic stability by preventing re-replication and coordinating DNA synthesis with other cell cycle events.
Why Is negative regulation of mitotic cell cycle DNA replication Important in Cell Biology?
Negative regulation of mitotic cell cycle DNA replication is fundamental for genomic integrity. Without proper control, cells may re-replicate their DNA or enter mitosis with incompletely replicated genomes, leading to aneuploidy and cancer. This process is also a target for cancer therapy, as inhibiting negative regulators like WEE1 can force cancer cells with defective checkpoints to undergo mitotic catastrophe. Thus, understanding GO:1903464 has direct implications for both basic cell biology and clinical oncology.
• Prevents re-replication and ensures once-per-cycle DNA duplication.
• Coordinates S phase with mitosis to avoid genome instability.
• Loss of negative regulation leads to unscheduled proliferation and cancer.
• WEE1 kinase is a key negative regulator and a therapeutic target [3,4].
• Rb1 deficiency creates synthetic lethality with ATR and PKMYT1 inhibition.
• WEE1 inhibitors can trigger the integrated stress response, affecting efficacy.
• Mus81-Eme1 nuclease activity is cell cycle-regulated, linking to replication stress.
• PLK1 is involved in DNA damage response and mitotic regulation.
• CENP-A assembly is cell cycle controlled, impacting chromosome segregation.
• Plant cell cycle studies provide evolutionary insights into conserved regulation.
What Happens During negative regulation of mitotic cell cycle DNA replication?
Initiation of DNA Replication and Checkpoint Activation
In simple terms: Before DNA copying starts, cells have checkpoints that can stop the process if conditions are not right.
DNA replication begins at origins of replication during S phase. Negative regulation can occur at initiation, preventing firing of excess origins. The ATR kinase is activated by replication stress and phosphorylates downstream targets to slow down or halt replication. Rb1 restricts S-phase entry by inhibiting E2F transcription factors.
Inhibition of CDK1 Activity by WEE1
In simple terms: WEE1 acts as a brake on the cell cycle engine, preventing entry into mitosis until DNA is fully copied.
WEE1 kinase phosphorylates CDK1 at Tyr15, inhibiting its activity and delaying mitotic entry when replication is incomplete. This provides time for DNA repair and completion of replication. WEE1 inhibitors are being tested in clinical trials, but they can activate the integrated stress response via GCN2, which may limit their efficacy.
Role of PKMYT1 and ATR in Replication Checkpoint
In simple terms: PKMYT1 and ATR work together to ensure that cells with damaged or unreplicated DNA do not divide.
PKMYT1 also phosphorylates CDK1 to inhibit mitotic entry. In Rb1-deficient breast cancer, co-inhibition of ATR and PKMYT1 induces synthetic lethality, highlighting the importance of these negative regulators. ATR coordinates the replication stress response, preventing fork collapse and ensuring replication completion.
Resolution of Replication Intermediates and Mitotic Entry
In simple terms: After DNA is copied, special enzymes clean up any tangles before the cell divides.
The Mus81-Eme1 nuclease resolves recombination intermediates during replication and is regulated in a cell cycle-dependent manner. PLK1 plays a role in DNA damage response and mitotic progression, linking replication completion to mitosis. CENP-A assembly is also cell cycle controlled, ensuring proper chromosome segregation.
Key Genes Involved in GO:1903464 negative regulation of mitotic cell cycle DNA replication
The following genes and proteins are key players in the negative regulation of mitotic cell cycle DNA replication, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| WEE1 | Phosphorylates CDK1 to inhibit mitotic entry | Target for cancer therapy; inhibitor trials ongoing |
| CDK1 | Central cell cycle kinase; inhibited by WEE1 | Key node in checkpoint control; target for inhibitors |
| RB1 | Restricts S-phase entry by inhibiting E2F | Tumor suppressor; loss leads to unscheduled replication |
| ATR | Replication stress response kinase | Synthetic lethal with Rb1 deficiency |
| PKMYT1 | Phosphorylates CDK1 to inhibit mitosis | Synthetic lethal target in Rb1-deficient cancers |
| PLK1 | Regulates DNA damage response and mitosis | Potential target in cancers with replication stress |
| MUS81 | Resolves recombination intermediates | Linked to replication fork stability |
| EME1 | Partner of MUS81 nuclease | Cell cycle-regulated nuclease activity |
| CENP-A | Histone H3 variant for centromere identity | Assembly is cell cycle controlled |
| GCN2 | Kinase activated by WEE1 inhibition | Mediates integrated stress response |
| CDC25 | Phosphatase that activates CDK1 | Opposes WEE1; not directly cited but implied in |
| TP53 | Guardian of the genome; induces cell cycle arrest | Frequently mutated in cancers with replication stress |
| CHEK1 | Checkpoint kinase downstream of ATR | Potential target in combination therapies |
| E2F1 | Transcription factor promoting S-phase genes | Inhibited by Rb1 |
| ORC1 | Origin recognition complex subunit | Involved in replication licensing |
| MCM2-7 | Replicative helicase | Regulated to prevent re-replication |
| CDT1 | Licensing factor | Degraded to prevent re-replication |
| GEMININ | Inhibits CDT1 to prevent re-replication | Key negative regulator of replication licensing |
How Is negative regulation of mitotic cell cycle DNA replication Regulated?
The negative regulation of mitotic cell cycle DNA replication is itself tightly controlled. WEE1 activity is regulated by phosphorylation and degradation, and its expression is cell cycle-dependent. The integrated stress response, mediated by GCN2, can be activated upon WEE1 inhibition, potentially affecting the efficacy of WEE1 inhibitors. Additionally, the ATR-CHK1 pathway is activated by replication stress to enforce checkpoints. Rb1 and E2F feedback loops also modulate S-phase entry. These regulatory layers ensure that DNA replication is properly timed and coordinated with other cell cycle events.
negative regulation of mitotic cell cycle DNA replication and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RB1 | Breast cancer, retinoblastoma | Rb1 knockout breast cancer cell lines and PDX |
| WEE1 | Cancer, chemoresistance | WEE1 knockout or inhibitor-treated cell lines |
| ATR | Cancer, replication stress | ATR knockout or inhibitor-treated cells |
| PKMYT1 | Breast cancer, synthetic lethality | PKMYT1 knockout in Rb1-deficient cells |
| MUS81 | Genomic instability, cancer | MUS81 knockout cells for replication stress assays |
Cancer and Genomic Instability
Loss of negative regulation of DNA replication leads to unscheduled proliferation and genomic instability, a hallmark of cancer. Rb1 deficiency, common in breast cancer, creates a dependency on ATR and PKMYT1, making these kinases attractive therapeutic targets. WEE1 inhibitors are being tested in clinical trials, but they can induce the integrated stress response, which may limit their effectiveness. Understanding these pathways is crucial for developing rational combination therapies.
Therapeutic Targeting of Checkpoint Kinases
Inhibitors of WEE1, ATR, and PKMYT1 are in clinical development. Preclinical studies show that co-inhibition of ATR and PKMYT1 is synthetically lethal in Rb1-deficient breast cancer models. However, WEE1 inhibition alone can trigger GCN2-mediated stress responses, highlighting the need for biomarkers and combination strategies. These findings underscore the importance of GO:1903464 in cancer therapy.
Other Diseases and Processes
Dysregulation of cell cycle checkpoints is also implicated in developmental disorders and neurodegeneration, though direct links to GO:1903464 are less established. The plant cell cycle provides evolutionary context, showing conservation of core regulatory mechanisms. Further research is needed to fully elucidate the role of this process in non-cancer pathologies.
From negative regulation of mitotic cell cycle DNA replication-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does WEE1 negatively regulate mitotic DNA replication? | WEE1 knockout cell lines |
| What is the effect of Rb1 loss on replication timing? | Rb1 knockout breast cancer cells |
| Can point mutations in CDK1 bypass WEE1 inhibition? | CDK1 T14A/Y15F knock-in cells |
| How does ATR inhibition affect replication fork stability? | ATR knockout or inhibitor-treated cells |
| Does PKMYT1 inhibition synergize with ATR inhibition? | PKMYT1 knockout in Rb1-deficient cells |
| What is the role of MUS81 in replication completion? | MUS81 knockout cells |
How to Study the negative regulation of mitotic cell cycle DNA replication Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Identify pathways affected by WEE1 inhibition |
| Phosphoproteomics | Phosphorylation events | Map CDK1 phosphorylation by WEE1 |
| Live-cell imaging | Replication dynamics | Visualize fork progression and stalling |
| CRISPR knockout screen | Gene essentiality | Discover synthetic lethal interactions |
| Flow cytometry | Cell cycle distribution | Assess S-phase entry and arrest |
| Western blot | Protein expression and modification | Validate WEE1 and CDK1 phosphorylation |
| Comet assay | DNA damage | Measure replication stress-induced damage |
Genomic and Transcriptomic Approaches
RNA sequencing (RNA-seq) can reveal changes in gene expression upon perturbation of negative regulators. For example, WEE1 inhibition alters stress response gene expression. Whole-genome sequencing can detect re-replication events. These methods help identify pathways affected by loss of GO:1903464 components.
Proteomic and Phosphoproteomic Analysis
Phosphoproteomics is essential to map the signaling cascades downstream of WEE1, ATR, and CDK1. It can identify substrates and feedback loops. For instance, WEE1 phosphorylates CDK1 at Tyr15, and mass spectrometry can quantify this modification.
Imaging and Single-Cell Techniques
Live-cell imaging with fluorescently tagged replication proteins (e.g., PCNA) can visualize replication dynamics in real time. Single-cell analysis can reveal heterogeneity in replication timing. These techniques are powerful for studying how negative regulation affects individual cells.
CRISPR-Based Functional Genomics
CRISPR knockout screens can identify genes that are essential when negative regulators are lost. For example, synthetic lethal screens in Rb1-deficient cells identified PKMYT1 and ATR. These screens are invaluable for discovering new therapeutic targets.
How CRISPR Can Be Used to Study GO:1903464 negative regulation of mitotic cell cycle DNA replication
Knockout
CRISPR knockout of negative regulators such as WEE1, ATR, or PKMYT1 can reveal their essential roles in preventing re-replication. For example, WEE1 knockout sensitizes cells to replication stress. Knockout models are also used in synthetic lethal screens.
Point Mutation
Point mutations can be introduced to mimic phosphorylation-defective or constitutively active forms of key proteins. For instance, CDK1 T14A/Y15F mutations prevent WEE1-mediated inhibition, leading to premature mitosis. Such models help dissect the precise phosphorylation events controlling replication.
Knock-in
Knock-in of tagged versions of proteins (e.g., GFP-WEE1) allows live-cell imaging and proteomic analysis. Knock-in of disease-associated mutations can model cancer predisposition. These models are valuable for studying protein localization and dynamics.
Overexpression
Overexpression of negative regulators like WEE1 can induce cell cycle arrest and protect against replication stress. Conversely, overexpression of positive regulators may overcome checkpoints. These models are used to test hypotheses about dosage effects.
How EDITGENE Supports negative regulation of mitotic cell cycle DNA replication Research
Researchers studying negative regulation of mitotic cell cycle DNA replication-related genes often need to determine whether a candidate gene is causally involved in checkpoint control, replication timing, or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of mitotic cell cycle DNA replication research.
Frequently Asked Questions About negative regulation of mitotic cell cycle DNA replication
What is GO:1903464?
GO:1903464 is a Gene Ontology term for negative regulation of mitotic cell cycle DNA replication, describing processes that stop or reduce DNA replication during the mitotic cell cycle.
What genes are involved in negative regulation of mitotic cell cycle DNA replication?
Key genes include WEE1, CDK1, RB1, ATR, PKMYT1, PLK1, MUS81, and EME1 [1,2,3,5,6].
Why is negative regulation of DNA replication important?
It prevents re-replication and ensures genomic stability, coordinating DNA synthesis with mitosis.
How is WEE1 involved in this process?
WEE1 phosphorylates CDK1 to inhibit mitotic entry when replication is incomplete.
What diseases are associated with defects in this process?
Cancer and genomic instability are strongly linked, particularly with Rb1 loss and WEE1 dysregulation [2,4].
What experimental models are used to study GO:1903464?
CRISPR knockout, point mutation, knock-in, and overexpression cell models, as well as CRISPR screens [2,3].
How can I study negative regulation of mitotic DNA replication in my lab?
Use CRISPR to knock out candidate genes, then assess replication dynamics by imaging or flow cytometry [1,3].
What is the role of ATR in this process?
ATR is a kinase that responds to replication stress and enforces checkpoints to prevent premature mitosis.
Are there drugs targeting this pathway?
Yes, WEE1, ATR, and PKMYT1 inhibitors are in clinical trials for cancer [2,4].
What services does EDITGENE offer for this research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services.
Conclusion
GO:1903464, negative regulation of mitotic cell cycle DNA replication, is a critical biological process that safeguards genome integrity by preventing re-replication and coordinating DNA synthesis with mitosis. Key regulators such as WEE1, ATR, and PKMYT1 are promising therapeutic targets, particularly in cancers with defective checkpoints. Understanding this process requires a combination of genetic, biochemical, and imaging approaches. EDITGENE offers a comprehensive suite of CRISPR services to facilitate this research, from knockout models to library screening, enabling researchers to dissect the molecular mechanisms and disease relevance of this pathway.
References
- 1. Shrestha S et al.. 2026. Mitotic kinase regulation of DNA replication forks.. bioRxiv PMID: 42239444
- 2. Jiang XT et al.. 2025. Rb1 deficiency induces synthetic lethality with ATR and PKMYT1 coinhibition in breast cancer cell lines and patient-derived xenografts.. Sci Transl Med 17(830):eadx6797 PMID: 41442499
- 3. McGowan CH et al.. 1995. Cell cycle regulation of human WEE1.. EMBO J 14(10):2166-75 PMID: 7774574
- 4. Tjeerdsma RB et al.. 2025. WEE1 inhibitors trigger GCN2-mediated activation of the integrated stress response.. Nat Commun 16(1):11598 PMID: 41285872
- 5. Gallo-Fernández M et al.. 2012. Cell cycle-dependent regulation of the nuclease activity of Mus81-Eme1/Mms4.. Nucleic Acids Res 40(17):8325-35 PMID: 22730299
- 6. Li W et al.. 2024. Polo-Like Kinase 1 and DNA Damage Response.. DNA Cell Biol 43(9):430-437 PMID: 38959179
- 7. Rowley G et al.. 2025. A brief historical perspective on cell cycle control of CENP-A assembly and inheritance.. Chromosome Res 33(1):15 PMID: 40715876
- 8. Francis D. 2007. The plant cell cycle--15 years on.. New Phytol 174(2):261-278 PMID: 17388890
